ACADIA Pharmaceuticals Inc.San Diego, CA, United States (NASDAQ (GM): ACAD)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

ACADIA Pharmaceuticals Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 07 Dec 06 Dec 05
Revenue 7.6 8.1 11.0
Cost of Goods Sold -- -- --
Gross Profit -- -- --
Gross Profit Margin 0.0% 0.0% 0.0%
SG&A Expense 69.4 57.3 45.7
Depreciation & Amortization 0.8 (0.2) 1.0
Operating Income (62.7) (49.0) (35.8)
Operating Margin -- -- --
Nonoperating Income 6.5 4.2 1.9
Nonoperating Expenses 0.3 0.2 0.2
Income Before Taxes (56.4) (45.1) (34.1)
Income Taxes -- -- --
Net Income After Taxes (56.4) (45.1) (34.1)

Continuing Operations (56.4) (45.1) (34.1)
Discontinued Operations -- 0.1 --
Total Operations (56.4) (45.0) (34.1)
Total Net Income (56.4) (45.0) (34.1)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (1.60) (1.61) (1.55)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online